Wildy Logo
(020) 7242 5778

Book of the Month

Cover of Taylor on Criminal Appeals

Taylor on Criminal Appeals

Edited by: Paul Taylor QC
Price: £240.00

Saggerson on Travel Law and Litigation 7th ed


Welcome to Wildys


A Practitioner's Guide to Probate Disputes 2nd ed


Offers for Newly Called Barristers & Students

Special Discounts for Newly Called & Students

Read More ...

Secondhand & Out of Print

Browse Secondhand Online


Evergreening Patent Exclusivity in Pharmaceutical Products: Supplementary Protection Certificates, Orphan Drugs, Paediatric Extensions and ATMPs (eBook)

ISBN13: 9781509950294
Published: October 2021
Publisher: Hart Publishing
Country of Publication: UK
Format: eBook (ePub)
Price: £81.00
The amount of VAT charged may change depending on your location of use.

The sale of some eBooks are restricted to certain countries. To alert you to such restrictions, please select the country of the billing address of your credit or debit card you wish to use for payment.

Billing Country:

Sale allowed in
Afghanistan , Albania, Algeria, American Samoa, Andorra, Angola, Anguilla, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bonaire, Saint Eustatius and Saba, Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde (Cabo Verde), Cayman Islands, Central African Republic, Chad, Chile, China, Christmas Island, Cocos (Keeling) Islands, Colombia, Comoros, Congo, The Democratic Republic Of The, Cook Islands, Costa Rica, Croatia, Cuba, Curaçao, Cyprus, Czech Republic, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Falkland Islands (Malvinas), Faroe Islands, Fiji, Finland, France, French Guiana, French Polynesia, French Southern Territories, Gabon , Gambia, Georgia, Germany, Ghana, Gibraltar, Greece, Greenland, Grenada, Guadeloupe, Guam, Guatemala, Guernsey, Guinea, Guinea-Bissau, Guyana, Haiti, Heard Island and Mcdonald Islands, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Islamic Republic Of, Iraq, Ireland, Israel, Italy, Ivory Coast (Côte d'Ivoire), Jamaica, Japan, Jersey, Jordan, Kazakhstan, Kenya, Kiribati, Korea, Democratic Peoples Republic Of, Korea, Republic Of, Kuwait, Kyrgyzstan, Lao Peoples Democratic Republic , Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Macao, Macedonia, The Former Yugoslav Republic Of, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Martinique, Mauritania, Mauritius, Mayotte, Mexico, Micronesia, Federated States Of, Moldova, Republic Of, Monaco, Mongolia, Montenegro, Montserrat, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norfolk Island, Northern Mariana Islands, Norway, Oman, Pakistan, Palau, Palestine, State of, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Pitcairn, Poland, Portugal, Puerto Rico, Qatar, Romania, Russian Federation, Rwanda, Saint Barthélemy, Saint Helena , Saint Kitts and Nevis, Saint Lucia, Saint Martin (French part), Saint Pierre and Miquelon, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Sint Maarten (Dutch part), Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Georgia and the South Sandwich Islands, Spain, Sri Lanka, Sudan, Suriname, Svalbard and Jan Mayen, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Taiwan, Tajikistan, Tanzania, United Republic Of, Thailand, Timor-Leste, Togo, Tokelau, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Turks and Caicos Islands, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom, United States, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, Virgin Islands (British), Virgin Islands (U.S.), Wallis and Futuna, Western Sahara, Yemen, Zambia, Zimbabwe

Due to publisher restrictions, international orders for ebooks may need to be confirmed by our staff during shop opening hours. Our trading hours are Monday to Friday, 8.45am to 6.00pm, London, UK time.

Once the order is confirmed an automated e-mail will be sent to you to allow you to download the eBook.

All eBooks are supplied firm sale and cannot be returned. If you believe there is a fault with your eBook then contact us on ebooks@wildy.com and we will help in resolving the issue. This does not affect your statutory rights.

This eBook is available in the following formats: ePub.

In stock.
Need help with ebook formats?

Also available as

This book analyses 4 central pieces of EU pharmaceutical regulation: the Orphan Drugs Regulation, the Paediatric Regulation, the Supplementary Protection Certificate Regulation, and the ATMP (Advanced Therapy Medicinal Products) Regulation. These four regulatory instruments constitute focal points in the pharmaceutical industry's approach to modern business and legal strategy. Their central role is justified by the way these regulatory instruments interact with each other and with the patent system, and by the considerable impact they (as a whole) have for the evergreening of exclusive rights on pharmaceutical products.

The book guides the reader through the latest case law and legislative developments and discusses how these influence strategic legal and business choices in the pharmaceutical industry. It brings to the forefront the often-overlooked significance of the legislative architecture of the EU pharmaceutical regulatory framework, and evaluates its results through the lens of the efficiency test.

The book is an important resource for academics and practitioners interested in updated case law and an in-depth analysis of these four regulations. It is als

Intellectual Property Law, eBooks
Table of Cases
Table of Legislation
1. Regulating the EU Pharmaceutical Sector: A Multilayer Challenge
1. The Pharmaceutical Sector: A Need for Regulation
2. The Structure of the Pharmaceutical Industry in Europe
3. EU Competence in the Field of Public Health
4. Effective Legislation and Regulatory Rights
5. The Structure of the Book
2. Setting the Stage for Regulatory Rights: The Regulatory Agencies and the Marketing Authorisation Procedure
1. Regulatory Authorities
2. The Marketing Authorisation Procedure
3. Concluding Remarks
3. Data Exclusivity
1. The Legal Framework
2. Clinical Data
3. The Marketing Authorisation Procedure and Directive 2001/83 – Original Pharmaceuticals
4. Marketing Authorisation for Generic Products
5. The Weaknesses of the System
6. Data Exclusivity for Paediatric Medicines That Are Not Patent-Protected
7. Concluding Remarks
4. The Supplementary Protection Certificate
1. Background to the Legal Framework
2. The Legal Framework
3. The Subject of Protection
4. The Rights Granted
5. The SPC Beneficiary
6. Concluding Remarks
5. The Paediatric Extension
1. Background
2. The General Legal Framework
3. A New Committee to Implement the Legal Framework: The Role of the Paediatric Committee (PDCO)
4. The PIP
5. PIP Compliance Control
6. Exemptions and Waivers
7. The Incentives of the Regulation
8. Rewards for Orphan Medicinal Products Under Regulation 1901/2006
9. Other Incentives in the System
10. Post-Approval Obligations
11. Concluding Remarks
6. Orphan Drugs
1. Background to the Legal Framework
2. Procedural Aspects
3. The Criteria for Orphan Drugs Designation
4. Marketing Authorisation of Orphan Drugs
5. The Incentives of the Orphan Drug Designation
6. Post-Grant Obligations of the Sponsor
7. Difficulties in the Interpretation of Orphan Drugs Regulation Case Law
8. Concluding Remarks
7. Advanced Therapy Medicinal Products
1. The Legal Framework
2. Definitions of Key Terms in the ATMP Regulation
3. The ATMP Regulation and Other European Legislation
4. Marketing Authorisation for ATMPs
5. Post-Authorisation Requirements
6. Concluding Remarks
8. How Effective Is the Effectiveness Test in the Field of Regulatory Rights?
1. The Objectives
2. The Contents
3. The Context
4. The Results
5. General Conclusions